These findings also raise a note of caution with the design of anti-tumor drug therapies targeted to separase activity; as we have observed, inhibition of this enzyme with the goal of blocking its mitosis-directing function might simultaneously prevent the major anti-tumor defensive mechanism, apoptosis, thereby potentially confounding such a strategy. This evidence concerns the gene ESPL1 and neoplasm.